OUR TECHnology

Our platform is uniquely able to target multiple misfolded protein aggregates implicated in serious diseases

AN URGENT NEED

Learn about our approach to meet the dire need for new treatments for neurodegenerative diseases

LATEST NEWS

Proclara Biosciences Presents Preclinical Data Supporting the Development of GAIM-Based Therapies for Peripheral Amyloidoses at the 16th International Symposium on Amyloidosis